Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Alamar Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -45.1% | +3.9 |
| Q2 FY2026 | Jun 30, 2026 | -46.0% | +19.3 |
| Q1 FY2026 | Mar 31, 2026 | -47.4% | – |
| Q3 FY2025 | Sep 30, 2025 | -39.6% | – |
| Q2 FY2025 | Jun 30, 2025 | -49.0% | – |
| Q1 FY2025 | Mar 31, 2025 | -65.3% | – |
See a number that looks wrong?